These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1442 related articles for article (PubMed ID: 9202061)

  • 1. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
    Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
    Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
    van Meurs JB; van Lent PL; Holthuysen AE; Singer II; Bayne EK; van den Berg WB
    Arthritis Rheum; 1999 Jun; 42(6):1128-39. PubMed ID: 10366105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
    Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT
    J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage.
    Di Cesare PE; Carlson CS; Stolerman ES; Hauser N; Tulli H; Paulsson M
    J Orthop Res; 1996 Nov; 14(6):946-55. PubMed ID: 8982138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage.
    Zack MD; Arner EC; Anglin CP; Alston JT; Malfait AM; Tortorella MD
    Arthritis Rheum; 2006 Sep; 54(9):2912-22. PubMed ID: 16948117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
    Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
    Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
    Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
    Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ceramide on aggrecanase activity in rabbit articular cartilage.
    Sabatini M; Thomas M; Deschamps C; Lesur C; Rolland G; de Nanteuil G; Bonnet J
    Biochem Biophys Res Commun; 2001 May; 283(5):1105-10. PubMed ID: 11355886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.